Avez Sharipov
Avez Sharipov publishes mostly in Molecular Biology, Pharmacology and Plant Science, on topics such as Pharmacological Effects of Natural Compounds, Polysaccharides and Plant Cell Walls and Natural product bioactivities and synthesis.
- World rank
- #3,324,053 of 7,710,434 ranked researchers
- Rank in Uzbekistan
- #400 of 3,371
- Works
- 32
- Citations
- 172
- Citations per work
- 5.4
What does Avez Sharipov research?
Avez Sharipov's work is mostly in Biochemistry, Genetics and Molecular Biology (21%), Medicine (12%), Pharmacology, Toxicology and Pharmaceutics (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1751.7%
- Life Sciences1236.8%
- Health Sciences411.5%
- Medicine411.5%
- 1Molecular Biology16% of their works
- 2Pharmacology9% of their works
- 3Plant Science7% of their works
- 4Pharmacology7% of their works
- 5Biochemistry5% of their works
- 6Neurology5% of their works
Research topics
- Pharmacological Effects of Natural Compounds
- Polysaccharides and Plant Cell Walls
- Natural product bioactivities and synthesis
- Fungal Biology and Applications
- Seaweed-derived Bioactive Compounds
- Biochemical Acid Research Studies
- Advanced Nanomaterials in Catalysis
- Advanced biosensing and bioanalysis techniques
Which keywords describe Avez Sharipov's research?
The keywords of their largest research topics: Antioxidant, Antiviral, Cancer, Bioactive Compounds, Biological Activities, Inflammation, Polysaccharides and Antioxidant Activity.
- Self-Assembly
- Seaweed
- Peroxidase-Like Activity
- Lipoic Acid
- Triterpenoids
- Pectin
- Hemicelluloses
- Licorice
- Nutritional Value
- Antioxidant Activity
- Inflammation
- Bioactive Compounds
- Antiviral
- Antioxidant
- Cancer
- Biological Activities
- Polysaccharides
- Biomedical Applications
- Glycyrrhizin
- Cancer Therapy
- Medicinal Mushrooms
- Saponins
- Functional Food
- Nanozymes
- Pyruvate Dehydrogenase Complex
- DNA nanotechnology
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 26 words, with their numbers
- Antioxidant123 topics
- Antiviral92 topics
- Cancer92 topics
- Bioactive Compounds82 topics
- Biological Activities82 topics
- Inflammation82 topics
- Polysaccharides82 topics
- Antioxidant Activity72 topics
- Biomedical Applications72 topics
- Nutritional Value72 topics
- Glycyrrhizin51 topic
- Licorice51 topic
- Cancer Therapy41 topic
- Hemicelluloses41 topic
- Medicinal Mushrooms41 topic
- Pectin41 topic
- Saponins41 topic
- Triterpenoids41 topic
- Functional Food31 topic
- Lipoic Acid31 topic
- Nanozymes31 topic
- Peroxidase-Like Activity31 topic
- Pyruvate Dehydrogenase Complex31 topic
- Seaweed31 topic
- DNA nanotechnology21 topic
- Self-Assembly21 topic
Where does Avez Sharipov work?
Avez Sharipov's main affiliation in the publication record is Tashkent Pharmaceutical Institute, Uzbekistan.
How many publications and citations does Avez Sharipov have?
OpenAlex counts 32 works and 172 citations for Avez Sharipov, an h-index of 7, ranking #3,324,053 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Avez Sharipov. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.